Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy.
Bhausaheb Pandurang BagalRup SarmaSayak DeyLingaraj NayakAvinash BondaJayant Sastri GodaNehal KhannaArchya DasguptaSangeeta KakotiAbhishek ChatarjeeHashmukh JainSridhar EpariSiddhartha LaskarManju SengarTejpal GuptaPublished in: British journal of haematology (2023)
Keyphrases
- early stage
- diffuse large b cell lymphoma
- resting state
- white matter
- radiation therapy
- locally advanced
- newly diagnosed
- radiation induced
- stem cell transplantation
- cerebrospinal fluid
- functional connectivity
- stem cells
- squamous cell carcinoma
- low dose
- chronic lymphocytic leukemia
- cell therapy
- mesenchymal stem cells
- bone marrow
- high dose
- subarachnoid hemorrhage
- blood brain barrier
- smoking cessation